Results: 1-25 | 26-27
Results: 1-25/27
ACETYLCHOLINESTERASE INHIBITION BY ZIFROSILONE - PHARMACOKINETICS ANDPHARMACODYNAMICS
Authors: CUTLER NR SEIFERT RD SCHLEMAN MM SRAMEK JJ SZYLLEYKO OJ HOWARD DR BARCHOWSKY A WARDLE TS BRASS EP
Citation: Nr. Cutler et al., ACETYLCHOLINESTERASE INHIBITION BY ZIFROSILONE - PHARMACOKINETICS ANDPHARMACODYNAMICS, Clinical pharmacology and therapeutics, 58(1), 1995, pp. 54-61
CARNITINE DELAYS RAT SKELETAL-MUSCLE FATIGUE IN-VITRO
Authors: BRASS EP SCARROW AM RUFF LJ MASTERSON KA VANLUNTEREN E
Citation: Ep. Brass et al., CARNITINE DELAYS RAT SKELETAL-MUSCLE FATIGUE IN-VITRO, Journal of applied physiology, 75(4), 1993, pp. 1595-1600
CARNITINE MAY BENEFIT ATHLETES - AUTHOR REPLY
Authors: BRASS EP HIATT WR
Citation: Ep. Brass et Wr. Hiatt, CARNITINE MAY BENEFIT ATHLETES - AUTHOR REPLY, Journal of the American College of Nutrition, 17(6), 1998, pp. 649-650
CARNITINE METABOLISM DURING EXERCISE
Authors: BRASS EP HIATT WR
Citation: Ep. Brass et Wr. Hiatt, CARNITINE METABOLISM DURING EXERCISE, Life sciences, 54(19), 1994, pp. 1383-1393
CLINICAL CHARACTERIZATION OF THROMBOTIC MICROANGIOPATHY IN HIV-INFECTION
Authors: KADO DM KOROTZER BS BRASS EP
Citation: Dm. Kado et al., CLINICAL CHARACTERIZATION OF THROMBOTIC MICROANGIOPATHY IN HIV-INFECTION, AIDS, 10(14), 1996, pp. 1747-1749
CLINICAL-TRIALS FOR CLAUDICATION - ASSESSMENT OF EXERCISE PERFORMANCE, FUNCTIONAL STATUS, AND CLINICAL END-POINTS
Authors: HIATT WR HIRSCH AT REGENSTEINER JG BRASS EP
Citation: Wr. Hiatt et al., CLINICAL-TRIALS FOR CLAUDICATION - ASSESSMENT OF EXERCISE PERFORMANCE, FUNCTIONAL STATUS, AND CLINICAL END-POINTS, Circulation, 92(3), 1995, pp. 614-621
DIETARY SUBSTITUTION OF MEDIUM-CHAIN TRIGLYCERIDES IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN AN AMBULATORY SETTING - IMPACT ON GLYCEMIC CONTROL AND INSULIN-MEDIATED GLUCOSE-METABOLISM
Authors: YOST TJ ERSKINE JM GREGG TS PODLECKI DL BRASS EP ECKEL RH
Citation: Tj. Yost et al., DIETARY SUBSTITUTION OF MEDIUM-CHAIN TRIGLYCERIDES IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN AN AMBULATORY SETTING - IMPACT ON GLYCEMIC CONTROL AND INSULIN-MEDIATED GLUCOSE-METABOLISM, Journal of the American College of Nutrition, 13(6), 1994, pp. 615-622
DOSE-RANGING STUDY OF A NEW, ONCE-DAILY DILTIAZEM FORMULATION FOR PATIENTS WITH STABLE ANGINA
Authors: CUTLER NR EFF J FROMELL G BRASS EP ARCHER S CHRYSANT SG FIDDES R
Citation: Nr. Cutler et al., DOSE-RANGING STUDY OF A NEW, ONCE-DAILY DILTIAZEM FORMULATION FOR PATIENTS WITH STABLE ANGINA, Journal of clinical pharmacology, 35(2), 1995, pp. 189-195
EFFECT OF EXERCISE TRAINING ON SKELETAL-MUSCLE HISTOLOGY AND METABOLISM IN PERIPHERAL ARTERIAL-DISEASE
Authors: HIATT WR REGENSTEINER JG WOLFEL EE CARRY MR BRASS EP
Citation: Wr. Hiatt et al., EFFECT OF EXERCISE TRAINING ON SKELETAL-MUSCLE HISTOLOGY AND METABOLISM IN PERIPHERAL ARTERIAL-DISEASE, Journal of applied physiology, 81(2), 1996, pp. 780-788
EFFECT OF INTRAVENOUS L-CARNITINE ON CARNITINE HOMEOSTASIS AND FUEL METABOLISM DURING EXERCISE IN HUMANS
Authors: BRASS EP HOPPEL CL HIATT WR
Citation: Ep. Brass et al., EFFECT OF INTRAVENOUS L-CARNITINE ON CARNITINE HOMEOSTASIS AND FUEL METABOLISM DURING EXERCISE IN HUMANS, Clinical pharmacology and therapeutics, 55(6), 1994, pp. 681-692
EFFECT OF THE ACE-INHIBITOR CERONAPRIL ON CEREBRAL BLOOD-FLOW IN HYPERTENSIVE PATIENTS
Authors: CUTLER NR SRAMEK JJ LUNA A MENA I BRASS EP KURTZ NM BRENNAN JJ
Citation: Nr. Cutler et al., EFFECT OF THE ACE-INHIBITOR CERONAPRIL ON CEREBRAL BLOOD-FLOW IN HYPERTENSIVE PATIENTS, The Annals of pharmacotherapy, 30(6), 1996, pp. 578-582
EFFECTS OF THE CHOLINOMIMETIC SDZ ENS-163 ON SCOPOLAMINE-INDUCED COGNITIVE IMPAIRMENT IN HUMANS
Authors: BRASS EP POLINSKY R SRAMEK JJ MOORE M JONES D VEROFF AE WARDLE TS CUTLER NR
Citation: Ep. Brass et al., EFFECTS OF THE CHOLINOMIMETIC SDZ ENS-163 ON SCOPOLAMINE-INDUCED COGNITIVE IMPAIRMENT IN HUMANS, Journal of clinical psychopharmacology, 15(1), 1995, pp. 58-62
GUIDELINES FOR ROUTINE LIVER-BIOPSY DURING METHOTREXATE TREATMENT - REPLY
Authors: BRASS EP
Citation: Ep. Brass, GUIDELINES FOR ROUTINE LIVER-BIOPSY DURING METHOTREXATE TREATMENT - REPLY, Cleveland Clinic journal of medicine, 61(4), 1994, pp. 318-318
HEPATIC COBALAMIN DEFICIENCY INDUCED BY HYDROXYCOBALAMIN[C-LACTAM] TREATMENT IN RATS IS ASSOCIATED WITH DECREASED MITOCHONDRIAL MESSENGER-RNA CONTENTS AND ACCUMULATION OF POLYCISTRONIC MITOCHONDRIAL RNAS
Authors: LEEDS FS BRASS EP
Citation: Fs. Leeds et Ep. Brass, HEPATIC COBALAMIN DEFICIENCY INDUCED BY HYDROXYCOBALAMIN[C-LACTAM] TREATMENT IN RATS IS ASSOCIATED WITH DECREASED MITOCHONDRIAL MESSENGER-RNA CONTENTS AND ACCUMULATION OF POLYCISTRONIC MITOCHONDRIAL RNAS, The Journal of biological chemistry, 269(6), 1994, pp. 3947-3951
HEPATIC TOXICITY OF ANTIRHEUMATIC DRUGS
Authors: BRASS EP
Citation: Ep. Brass, HEPATIC TOXICITY OF ANTIRHEUMATIC DRUGS, Cleveland Clinic journal of medicine, 60(6), 1993, pp. 466-472
HYDROXYCOBALAMIN[C-LACTAM] INCREASES TOTAL COENZYME-A CONTENT IN PRIMARY CULTURE HEPATOCYTES BY ACCELERATING COENZYME-A BIOSYNTHESIS SECONDARY TO ACYL-COA ACCUMULATION
Authors: BRASS EP
Citation: Ep. Brass, HYDROXYCOBALAMIN[C-LACTAM] INCREASES TOTAL COENZYME-A CONTENT IN PRIMARY CULTURE HEPATOCYTES BY ACCELERATING COENZYME-A BIOSYNTHESIS SECONDARY TO ACYL-COA ACCUMULATION, The Journal of nutrition, 123(11), 1993, pp. 1801-1807
INHIBITION OF GLUCAGON-STIMULATED GLYCOGENOLYSIS BY S-NITROSO-N-ACETYLPENICILLAMINE
Authors: BRASS EP VETTER WH
Citation: Ep. Brass et Wh. Vetter, INHIBITION OF GLUCAGON-STIMULATED GLYCOGENOLYSIS BY S-NITROSO-N-ACETYLPENICILLAMINE, Pharmacology & toxicology, 72(6), 1993, pp. 369-372
INOSITOL GLYCAN PHOSPHATE DERIVED FROM HUMAN ERYTHROCYTE ACETYLCHOLINESTERASE GLYCOLIPID ANCHOR AND INOSITOL CYCLIC 1,2-PHOSPHATE ANTAGONIZE GLUCAGON ACTIVATION OF GLYCOGEN-PHOSPHORYLASE
Authors: DEEG MA BRASS EP ROSENBERRY TL
Citation: Ma. Deeg et al., INOSITOL GLYCAN PHOSPHATE DERIVED FROM HUMAN ERYTHROCYTE ACETYLCHOLINESTERASE GLYCOLIPID ANCHOR AND INOSITOL CYCLIC 1,2-PHOSPHATE ANTAGONIZE GLUCAGON ACTIVATION OF GLYCOGEN-PHOSPHORYLASE, Diabetes, 42(9), 1993, pp. 1318-1323
INTERLEUKIN-6, BUT NOT TUMOR-NECROSIS-FACTOR-ALPHA, INCREASES LIPOGENESIS IN RAT HEPATOCYTE PRIMARY CULTURES
Authors: VETTER WH BRASS EP
Citation: Wh. Vetter et Ep. Brass, INTERLEUKIN-6, BUT NOT TUMOR-NECROSIS-FACTOR-ALPHA, INCREASES LIPOGENESIS IN RAT HEPATOCYTE PRIMARY CULTURES, Clinical research, 41(3), 1993, pp. 10000662-10000662
INTERLEUKIN-6, BUT NOT TUMOR-NECROSIS-FACTOR-ALPHA, INCREASES LIPOGENESIS IN RAT HEPATOCYTE PRIMARY CULTURES
Authors: BRASS EP VETTER WH
Citation: Ep. Brass et Wh. Vetter, INTERLEUKIN-6, BUT NOT TUMOR-NECROSIS-FACTOR-ALPHA, INCREASES LIPOGENESIS IN RAT HEPATOCYTE PRIMARY CULTURES, Biochemical journal, 301, 1994, pp. 193-197
METABOLIC PROFILES OF CAT AND RAT PHARYNGEAL AND DIAPHRAGM MUSCLES
Authors: VANLUNTEREN E BRASS EP
Citation: E. Vanlunteren et Ep. Brass, METABOLIC PROFILES OF CAT AND RAT PHARYNGEAL AND DIAPHRAGM MUSCLES, Respiration physiology, 105(3), 1996, pp. 171-177
OVERVIEW OF COENZYME-A METABOLISM AND ITS ROLE IN CELLULAR TOXICITY
Authors: BRASS EP
Citation: Ep. Brass, OVERVIEW OF COENZYME-A METABOLISM AND ITS ROLE IN CELLULAR TOXICITY, Chemico-biological interactions, 90(3), 1994, pp. 203-214
PHARMACOKINETIC CONSIDERATIONS FOR THE THERAPEUTIC USE OF CARNITINE IN HEMODIALYSIS-PATIENTS
Authors: BRASS EP
Citation: Ep. Brass, PHARMACOKINETIC CONSIDERATIONS FOR THE THERAPEUTIC USE OF CARNITINE IN HEMODIALYSIS-PATIENTS, Clinical therapeutics, 17(2), 1995, pp. 176-185
QUANTIFICATION OF CARNITINE, ACETYLCARNITINE, AND TOTAL CARNITINE IN TISSUES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - THE EFFECT OF EXERCISE ON CARNITINE HOMEOSTASIS IN MAN
Authors: MINKLER PE BRASS EP HIATT WR INGALLS ST HOPPEL CL
Citation: Pe. Minkler et al., QUANTIFICATION OF CARNITINE, ACETYLCARNITINE, AND TOTAL CARNITINE IN TISSUES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - THE EFFECT OF EXERCISE ON CARNITINE HOMEOSTASIS IN MAN, Analytical biochemistry, 231(2), 1995, pp. 315-322
ROLE OF L-CARNITINE IN TREATING RENAL DIALYSIS PATIENTS
Authors: AHMAD S BRASS EP HOPPEL C KOPPLE JD LASAGNA L LUNDIN AP SCHREINER GE SHERIDAN MJ
Citation: S. Ahmad et al., ROLE OF L-CARNITINE IN TREATING RENAL DIALYSIS PATIENTS, Dialysis & transplantation, 23(4), 1994, pp. 177
Risultati: 1-25 | 26-27